España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
4D Molecular Therapeutics
FDMT
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$6.31
0.53
9.17%
At close: -
$6.31
0.00
0.00%
After Hours: Dec 20, 5:25 PM EDT
Get Report
Comment
4D Molecular Therapeutics (FDMT) Forecast
News
Earnings
4D Molecular Therapeutics (FDMT) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for 4D Molecular Therapeutics (NASDAQ:FDMT) Stock
4D Molecular Therapeutics Stock (NASDAQ: FDMT)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Wednesday, December 18, 2024
What 5 Analyst Ratings Have To Say About 4D Molecular Therapeutics
Benzinga Insights
Amazon To Rally Around 21%? Here Are 10 Top Analyst Forecasts For Wednesday
Avi Kapoor
B of A Securities Maintains Buy on 4D Molecul...
Benzinga Newsdesk
Monday, December 16, 2024
4DMT Announces Landmark Publication Of 4D-150...
Benzinga Newsdesk
Thursday, November 21, 2024
Morgan Stanley Initiates Coverage On 4D Molec...
Benzinga Newsdesk
Thursday, November 14, 2024
Chardan Capital Maintains Buy on 4D Molecular...
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Buy on 4D Mole...
Benzinga Newsdesk
Analyst Expectations For 4D Molecular Therapeutics's Future
Benzinga Insights
RBC Capital Maintains Outperform on 4D Molecu...
Benzinga Newsdesk
Wednesday, November 13, 2024
4D Molecular Therapeutics Q3 2024 GAAP EPS $(...
Benzinga Newsdesk
Monday, September 23, 2024
Cantor Fitzgerald Downgrades 4D Molecular The...
Benzinga Newsdesk
Thursday, September 19, 2024
4D Molecular Therapeutics Stock Falls After Follow-Up Data From Mid-Stage Study Of Vision Loss Drug Candidate
Vandana Singh
Chardan Capital Maintains Buy on 4D Molecular...
Benzinga Newsdesk
4D Molecular Therapeutics shares are trading ...
Benzinga Newsdesk
Leerink Partners Reiterates Outperform on 4D ...
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Buy on 4D Mole...
Benzinga Newsdesk
Wednesday, September 18, 2024
4DMT Highlights Clinical Activity For 4D-150 ...
Benzinga Newsdesk
Monday, September 09, 2024
The Latest Analyst Ratings For 4D Molecular Therapeutics
Benzinga Insights
Cantor Fitzgerald Reiterates Overweight on 4D...
Benzinga Newsdesk
Friday, August 09, 2024
HC Wainwright & Co. Reiterates Buy on 4D Mole...
Benzinga Newsdesk
Thursday, August 08, 2024
4D Molecular Therapeutics Q2 EPS $(0.63) Beat...
Benzinga Newsdesk
Monday, July 22, 2024
RBC Capital Reiterates Outperform on 4D Molec...
Benzinga Newsdesk
Thursday, July 18, 2024
Why Domino's Pizza Shares Are Trading Lower By Over 11%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Avi Kapoor
Peeling Back The Layers: Exploring 4D Molecular Therapeutics Through Analyst Insights
Benzinga Insights
BMO Capital Maintains Outperform on 4D Molecu...
Benzinga Newsdesk
Wednesday, July 17, 2024
4DMT shares are trading lower. The company an...
Benzinga Newsdesk
Chardan Capital Maintains Buy on 4D Molecular...
Benzinga Newsdesk
4D Molecular Therapeutics Goes Neck To Neck With Rival, Shares New Phase 2 Data For Its Wet AMD Candidate
Vandana Singh
Why ASLAN Pharmaceuticals Shares Are Trading Lower By Over 38%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Avi Kapoor
4D Molecular Therapeutics Presents Phase 2 Tr...
Benzinga Newsdesk
Wednesday, June 26, 2024
Assessing 4D Molecular Therapeutics: Insights From 7 Financial Analysts
Benzinga Insights
RBC Capital Reiterates Outperform on 4D Molec...
Benzinga Newsdesk
Monday, June 24, 2024
4DMT Reports FDA Clearance Of IND Application...
Benzinga Newsdesk
Tuesday, June 18, 2024
4D Molecular Therapeutics to Present 24-Week ...
Benzinga Newsdesk
Monday, June 10, 2024
Reported Saturday, 4DMT Presented Injection-F...
Benzinga Newsdesk
Friday, June 07, 2024
4D Molecular Therapeutics Entered Into A Sale...
Benzinga Newsdesk
Goldman Sachs Optimistic About Regenxbio's Gene Therapy Pipeline, Sees Over 160% Upside
Vandana Singh
Analyst Expectations For 4D Molecular Therapeutics's Future
Benzinga Insights
HC Wainwright & Co. Reiterates Buy on 4D Mole...
Benzinga Newsdesk
Thursday, June 06, 2024
Why G-III Apparel Shares Are Trading Lower By 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Avi Kapoor
Why Is 4D Molecular Therapeutics Stock Trading Lower On Thursday? Genetic Disease-Focused Study Data Released
Vandana Singh
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga Insights
4D Molecular Therapeutics shares are trading ...
Benzinga Newsdesk
4D Molecular Therapeutics To Present Interim ...
Benzinga Newsdesk
Thursday, May 30, 2024
4D Molecular Therapeutics To Present Interim ...
Benzinga Newsdesk
Monday, May 13, 2024
HC Wainwright & Co. Reiterates Buy on 4D Mole...
Benzinga Newsdesk
Thursday, May 09, 2024
4D Molecular Therapeutics Q1 2024 GAAP EPS $(...
Benzinga Newsdesk
Thursday, April 18, 2024
To The Moon! A Look Inside An ETF Focused On Companies At The Cutting Edge Of Innovation
Johnny Rice
-
Sponsored
Monday, April 15, 2024
RBC Capital Maintains Outperform on 4D Molecu...
Benzinga Newsdesk
Barclays Initiates Coverage On 4D Molecular T...
Benzinga Newsdesk
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch